ENZYMOTEC LTD's ticker is ENZY and the CUSIP is M4059L101. A total of 23 filers reported holding ENZYMOTEC LTD in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $5,127,000 | +12.6% | 681,778 | 0.0% | 2.34% | +29.2% |
Q3 2014 | $4,554,000 | +397.7% | 681,778 | +910.6% | 1.81% | +440.9% |
Q2 2014 | $915,000 | -87.3% | 67,463 | -79.4% | 0.34% | -85.6% |
Q1 2014 | $7,222,000 | +31.7% | 327,962 | +61.6% | 2.32% | +39.7% |
Q4 2013 | $5,482,000 | – | 202,962 | – | 1.66% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TIGER MANAGEMENT L.L.C. | 804,854 | $7,284,000 | 0.97% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 96,600 | $874,000 | 0.33% |
Visium Asset Management, LP | 2,200,000 | $19,910,000 | 0.27% |
Paulson & Co. | 4,238,275 | $38,356,000 | 0.20% |
Rotella Capital Management, Inc. | 17,118 | $155,000 | 0.05% |
MENTA CAPITAL LLC | 15,870 | $144,000 | 0.02% |
Renaissance Technologies | 146,000 | $1,321,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 147,144 | $1,332,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 51,370 | $464,000 | 0.00% |
GOLDMAN SACHS GROUP INC | 947,723 | $8,577,000 | 0.00% |